Cargando…

Serum zinc levels in pediatric patients with COVID-19

Zinc has potent immunoregulatory and antiviral effects that are critical for growth, immunity, and neurologic development. The aim of this study was to determine the clinical significance of serum zinc levels in pediatric patients with COVID-19 and to demonstrate its association with disease severit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekemen Keleş, Yıldız, Yılmaz Çiftdoğan, Dilek, Çolak, Ayfer, Kara Aksay, Ahu, Üstündag, Gülnihan, Şahin, Aslıhan, Yılmaz, Nisel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782687/
https://www.ncbi.nlm.nih.gov/pubmed/35064310
http://dx.doi.org/10.1007/s00431-021-04348-w
_version_ 1784638364218032128
author Ekemen Keleş, Yıldız
Yılmaz Çiftdoğan, Dilek
Çolak, Ayfer
Kara Aksay, Ahu
Üstündag, Gülnihan
Şahin, Aslıhan
Yılmaz, Nisel
author_facet Ekemen Keleş, Yıldız
Yılmaz Çiftdoğan, Dilek
Çolak, Ayfer
Kara Aksay, Ahu
Üstündag, Gülnihan
Şahin, Aslıhan
Yılmaz, Nisel
author_sort Ekemen Keleş, Yıldız
collection PubMed
description Zinc has potent immunoregulatory and antiviral effects that are critical for growth, immunity, and neurologic development. The aim of this study was to determine the clinical significance of serum zinc levels in pediatric patients with COVID-19 and to demonstrate its association with disease severity. This prospective observational study was conducted between August 3 and November 15, 2020, in pediatric patients aged 1 month to 18 years with confirmed COVID-19 using reverse transcription-polymerase chain reaction. We defined a control group whose serum zinc levels were determined 1 year ago at the same time as those of patients with COVID-19. We used 70 μg/dL as the cut-off zinc value to define zinc deficiency. Statistical analyses were performed using the SPSS for Windows statistics package program. One hundred children with confirmed COVID-19 and 269 children in the control group participated in the study. The median age was 13.3 (IQR: 8–15.4) years in patients with confirmed COVID-19, 11 patients had low serum zinc levels, and 89 patients had normal serum zinc levels. Patients in the group with low zinc levels had a significantly higher hospitalization rate than the group with normal zinc levels (5 (45.5%) and 10 patients (11.2%), respectively) (p = 0.011). The median serum zinc level in patients with COVID-19 was 88.5 mcg/dL (IQR 77.2–100), which was significantly lower than the median level in the control group, which was 98 mcg/dL (IQR 84–111) (p = 0.001). There was no association between the severity of COVID-19 and the serum zinc levels of the children. Conclusion: Serum zinc levels may be influenced by many factors such as fasting status, diurnal variation, exercise, and sex, and may give an impression of the zinc status of the population rather than reflecting the individual. The fact that the incidence of hospitalization was significantly higher in patients with both COVID-19 and low serum zinc levels suggests that these patients require a detailed assessment of their living environment.
format Online
Article
Text
id pubmed-8782687
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87826872022-01-24 Serum zinc levels in pediatric patients with COVID-19 Ekemen Keleş, Yıldız Yılmaz Çiftdoğan, Dilek Çolak, Ayfer Kara Aksay, Ahu Üstündag, Gülnihan Şahin, Aslıhan Yılmaz, Nisel Eur J Pediatr Original Article Zinc has potent immunoregulatory and antiviral effects that are critical for growth, immunity, and neurologic development. The aim of this study was to determine the clinical significance of serum zinc levels in pediatric patients with COVID-19 and to demonstrate its association with disease severity. This prospective observational study was conducted between August 3 and November 15, 2020, in pediatric patients aged 1 month to 18 years with confirmed COVID-19 using reverse transcription-polymerase chain reaction. We defined a control group whose serum zinc levels were determined 1 year ago at the same time as those of patients with COVID-19. We used 70 μg/dL as the cut-off zinc value to define zinc deficiency. Statistical analyses were performed using the SPSS for Windows statistics package program. One hundred children with confirmed COVID-19 and 269 children in the control group participated in the study. The median age was 13.3 (IQR: 8–15.4) years in patients with confirmed COVID-19, 11 patients had low serum zinc levels, and 89 patients had normal serum zinc levels. Patients in the group with low zinc levels had a significantly higher hospitalization rate than the group with normal zinc levels (5 (45.5%) and 10 patients (11.2%), respectively) (p = 0.011). The median serum zinc level in patients with COVID-19 was 88.5 mcg/dL (IQR 77.2–100), which was significantly lower than the median level in the control group, which was 98 mcg/dL (IQR 84–111) (p = 0.001). There was no association between the severity of COVID-19 and the serum zinc levels of the children. Conclusion: Serum zinc levels may be influenced by many factors such as fasting status, diurnal variation, exercise, and sex, and may give an impression of the zinc status of the population rather than reflecting the individual. The fact that the incidence of hospitalization was significantly higher in patients with both COVID-19 and low serum zinc levels suggests that these patients require a detailed assessment of their living environment. Springer Berlin Heidelberg 2022-01-22 2022 /pmc/articles/PMC8782687/ /pubmed/35064310 http://dx.doi.org/10.1007/s00431-021-04348-w Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Ekemen Keleş, Yıldız
Yılmaz Çiftdoğan, Dilek
Çolak, Ayfer
Kara Aksay, Ahu
Üstündag, Gülnihan
Şahin, Aslıhan
Yılmaz, Nisel
Serum zinc levels in pediatric patients with COVID-19
title Serum zinc levels in pediatric patients with COVID-19
title_full Serum zinc levels in pediatric patients with COVID-19
title_fullStr Serum zinc levels in pediatric patients with COVID-19
title_full_unstemmed Serum zinc levels in pediatric patients with COVID-19
title_short Serum zinc levels in pediatric patients with COVID-19
title_sort serum zinc levels in pediatric patients with covid-19
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782687/
https://www.ncbi.nlm.nih.gov/pubmed/35064310
http://dx.doi.org/10.1007/s00431-021-04348-w
work_keys_str_mv AT ekemenkelesyıldız serumzinclevelsinpediatricpatientswithcovid19
AT yılmazciftdogandilek serumzinclevelsinpediatricpatientswithcovid19
AT colakayfer serumzinclevelsinpediatricpatientswithcovid19
AT karaaksayahu serumzinclevelsinpediatricpatientswithcovid19
AT ustundaggulnihan serumzinclevelsinpediatricpatientswithcovid19
AT sahinaslıhan serumzinclevelsinpediatricpatientswithcovid19
AT yılmaznisel serumzinclevelsinpediatricpatientswithcovid19